These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17089066)

  • 21. Involvement of both mitochondrial- and death receptor-dependent apoptotic pathways regulated by Bcl-2 family in sodium fluoride-induced apoptosis of the human gingival fibroblasts.
    Lee JH; Jung JY; Jeong YJ; Park JH; Yang KH; Choi NK; Kim SH; Kim WJ
    Toxicology; 2008 Jan; 243(3):340-7. PubMed ID: 18069112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between in vitro drug sensitivity and clinical response of patients to treatment in chronic lymphocytic leukemia.
    Rogalińska M; Błoński JZ; Góralski P; Wawrzyniak E; Hartman M; Rogalska A; Robak P; Koceva-Chyła A; Piekarski H; Robak T; Kiliańska ZM
    Int J Oncol; 2015 Mar; 46(3):1259-67. PubMed ID: 25572009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of apoptosis by monosaccharide butyrate stable derivatives in chronic lymphocytic leukemia cells.
    Santini V; Gozzini A; Scappini B; Caporale R; Zoccolante A; Rigacci L; Gelardi E; Grossi A; Alterini R; Ferrini PR
    Haematologica; 1999 Oct; 84(10):897-904. PubMed ID: 10509037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX.
    McConkey DJ; Chandra J; Wright S; Plunkett W; McDonnell TJ; Reed JC; Keating M
    J Immunol; 1996 Apr; 156(7):2624-30. PubMed ID: 8786328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases.
    Chow KU; Sommerlad WD; Boehrer S; Schneider B; Seipelt G; Rummel MJ; Hoelzer D; Mitrou PS; Weidmann E
    Haematologica; 2002 Jan; 87(1):33-43. PubMed ID: 11801463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. R-roscovitine (Seliciclib) affects CLL cells more strongly than combinations of fludarabine or cladribine with cyclophosphamide: Inhibition of CDK7 sensitizes leukemic cells to caspase-dependent apoptosis.
    Rogalińska M; Błoński JZ; Komina O; Góralski P; Zołnierczyk JD; Piekarski H; Robak T; Kiliańska ZM; Wesierska-Gadek J
    J Cell Biochem; 2010 Jan; 109(1):217-35. PubMed ID: 19911397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro evaluation of bendamustine induced apoptosis in B-chronic lymphocytic leukemia.
    Schwänen C; Hecker T; Hübinger G; Wölfle M; Rittgen W; Bergmann L; Karakas T
    Leukemia; 2002 Oct; 16(10):2096-105. PubMed ID: 12357363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of poly(ADP-ribosyl)ation in the killing of chronic lymphocytic leukemia cells by purine analogues.
    Pettitt AR; Sherrington PD; Cawley JC
    Cancer Res; 2000 Aug; 60(15):4187-93. PubMed ID: 10945628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bcl-2 regulatory pathway is functional in chronic lymphocytic leukemia.
    Goolsby C; Paniagua M; Tallman M; Gartenhaus RB
    Cytometry B Clin Cytom; 2005 Jan; 63(1):36-46. PubMed ID: 15624202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of cladribine alone and in combination with cyclophosphamide or cyclophosphamide and mitoxantrone on bone marrow angiogenesis in chronic lymphocytic leukemia.
    Szmigielska-Kapłon A; Jesionek-Kupnicka D; Góra-Tybor J; Błonski JZ; Lech-Marańda E; Kordek R; Kasznicki M; Robak T
    Leuk Lymphoma; 2007 May; 48(5):1042-4. PubMed ID: 17487753
    [No Abstract]   [Full Text] [Related]  

  • 31. Cladribine combined with cyclophosphamide and mitoxantrone as front-line therapy in chronic lymphocytic leukemia.
    Robak T; Błoński JZ; Kasznicki M; Góra-Tybor I; Dwilewicz-Trojaczek J; Boguradzki P; Konopka L; Ceglarek B; Sułek J; Kuliczkowski K; Wołowiec D; Stella-Hołowiecka B; Skotnicki AB; Nowak W; Moskwa-Sroka B; Dmoszyńska A; Calbecka M
    Leukemia; 2001 Oct; 15(10):1510-6. PubMed ID: 11587207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentiation of antitumor effects of cyclophosphamide derivatives in B-chronic lymphocytic leukemia cells by 2-chloro-2'-deoxyadenosine.
    Van Den Neste E; Bontemps F; Delacauw A; Cardoen S; Louviaux I; Scheiff JM; Gillis E; Leveugle P; Deneys V; Ferrant A; Van den Berghe G
    Leukemia; 1999 Jun; 13(6):918-25. PubMed ID: 10360381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of apoptosis by luteolin through cleavage of Bcl-2 family in human leukemia HL-60 cells.
    Cheng AC; Huang TC; Lai CS; Pan MH
    Eur J Pharmacol; 2005 Feb; 509(1):1-10. PubMed ID: 15713423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformational change and mitochondrial translocation of Bax accompany proteasome inhibitor-induced apoptosis of chronic lymphocytic leukemic cells.
    Dewson G; Snowden RT; Almond JB; Dyer MJ; Cohen GM
    Oncogene; 2003 May; 22(17):2643-54. PubMed ID: 12730678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bax cleavage implicates caspase-dependent H2O2-induced apoptosis of hepatocytes.
    Tamura H; Ohtsuru A; Kamohara Y; Fujioka H; Yanaga K; Kanematsu T; Yamashita S
    Int J Mol Med; 2003 Mar; 11(3):369-74. PubMed ID: 12579342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
    Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM
    Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cladribine alone and in combination with cyclophosphamide or cyclophosphamide plus mitoxantrone in the treatment of progressive chronic lymphocytic leukemia: report of a prospective, multicenter, randomized trial of the Polish Adult Leukemia Group (PALG CLL2).
    Robak T; Blonski JZ; Gora-Tybor J; Jamroziak K; Dwilewicz-Trojaczek J; Tomaszewska A; Konopka L; Ceglarek B; Dmoszynska A; Kowal M; Kloczko J; Stella-Holowiecka B; Sulek K; Calbecka M; Zawilska K; Kuliczkowski K; Skotnicki AB; Warzocha K; Kasznicki M;
    Blood; 2006 Jul; 108(2):473-9. PubMed ID: 16551966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells involves Bax translocation to mitochondria.
    Yu W; Sanders BG; Kline K
    Cancer Res; 2003 May; 63(10):2483-91. PubMed ID: 12750270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Doxorubicin and a butyric acid derivative effectively reduce levels of BCL-2 protein in the cells of chronic lymphocytic leukemia patient.
    Rabizadeh E; Bairey O; Aviram A; Ben-Dror I; Shaklai M; Zimra Y
    Eur J Haematol; 2001 Apr; 66(4):263-71. PubMed ID: 11380606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of caspases and apoptosis-inducing factor (AIF) in cladribine-induced apoptosis of B cell chronic lymphocytic leukemia.
    Pérez-Galán P; Marzo I; Giraldo P; Rubio-Félix D; Lasierra P; Larrad L; Anel A; Naval J
    Leukemia; 2002 Oct; 16(10):2106-14. PubMed ID: 12357364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.